Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
NSE India S.E.
12:05:09 17/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,580.00 INR | -1.04% |
|
+3.26% | -12.74% |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Cap 1 | 200,521 | 168,871 | 181,140 | - | - |
| Change | - | -15.78% | 7.27% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 189,996 | 182,304 | 181,140 |
| Change | - | -9.93% | 5.2% | -4.05% | -0.64% |
| P/E | -1,075x | -229x | 39x | 18.9x | - |
| PBR | - | - | 2.89x | 2.55x | 2.49x |
| PEG | - | -1x | -0x | 0x | - |
| Capitalization / Revenue | - | 11.9x | 8.31x | 5.32x | 6.08x |
| EV / Revenue | - | 12.7x | 8.72x | 5.36x | 6.08x |
| EV / EBITDA | - | 59.4x | 24.1x | 13.3x | 15.7x |
| EV / EBIT | - | 719x | 34.4x | 17.7x | 21.4x |
| EV / FCF | - | -32.2x | 34.3x | 24.3x | 23.4x |
| FCF Yield | - | -3.1% | 2.91% | 4.11% | 4.27% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 40.5 | 83.73 | - |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 14,216 | 21,798 | 34,019 | 29,769 |
| EBITDA 1 | - | 3,042 | 7,875 | 13,689 | 11,544 |
| EBIT 1 | - | 251.3 | 5,526 | 10,322 | 8,472 |
| Net income 1 | -179.7 | -738 | 4,459 | 8,968 | 7,308 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 | - |
| Reference price 2 | 1,752.25 | 1,473.30 | 1,580.00 | 1,580.00 | 1,580.00 |
| Nbr of stocks (in thousands) | 114,436 | 114,621 | 114,646 | - | - |
| Announcement Date | 05/05/25 | 13/05/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 39.42x | 8.8x | 24.37x | - | 1.91B | |
| 31.46x | 5.67x | 16.98x | 1.03% | 45.91B | |
| 34.62x | 3.34x | 14.39x | -.--% | 44.25B | |
| -20.04x | 230.9x | -21.44x | -.--% | 41.99B | |
| 45.6x | 5.26x | 28.79x | -.--% | 39.58B | |
| 26.88x | 8.11x | 20.55x | 0.42% | 31.08B | |
| 35.05x | 5.75x | 26.13x | -.--% | 17.21B | |
| 24.9x | 2.15x | 9.33x | 1.07% | 14.96B | |
| 29.53x | 1.94x | 11.89x | -.--% | 13.42B | |
| Average | 27.49x | 30.21x | 14.55x | 0.32% | 27.81B | |
| Weighted average by Cap. | 24.86x | 42.90x | 12.34x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
